- Home
- OPFI vs AMRN Comparison
OPFI vs AMRN Comparison
Compare OPFI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- AMRN
- Stock Information
- Founded
- OPFI 2009
- AMRN 1989
- Country
- OPFI United States
- AMRN Ireland
- Employees
- OPFI N/A
- AMRN N/A
- Industry
- OPFI Finance: Consumer Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- OPFI Finance
- AMRN Health Care
- Exchange
- OPFI Nasdaq
- AMRN Nasdaq
- Market Cap
- OPFI 343.1M
- AMRN 302.0M
- IPO Year
- OPFI N/A
- AMRN 1993
- Fundamental
- Price
- OPFI $9.86
- AMRN $19.97
- Analyst Decision
- OPFI Buy
- AMRN Strong Sell
- Analyst Count
- OPFI 2
- AMRN 1
- Target Price
- OPFI $11.75
- AMRN $12.00
- AVG Volume (30 Days)
- OPFI 936.0K
- AMRN 103.7K
- Earning Date
- OPFI 10-29-2025
- AMRN 10-29-2025
- Dividend Yield
- OPFI 10.13%
- AMRN N/A
- EPS Growth
- OPFI N/A
- AMRN N/A
- EPS
- OPFI N/A
- AMRN N/A
- Revenue
- OPFI $320,831,000.00
- AMRN $219,361,000.00
- Revenue This Year
- OPFI $118.17
- AMRN N/A
- Revenue Next Year
- OPFI $11.29
- AMRN N/A
- P/E Ratio
- OPFI N/A
- AMRN N/A
- Revenue Growth
- OPFI 31.26
- AMRN N/A
- 52 Week Low
- OPFI $4.78
- AMRN $7.08
- 52 Week High
- OPFI $17.73
- AMRN $20.43
- Technical
- Relative Strength Index (RSI)
- OPFI 39.22
- AMRN 74.89
- Support Level
- OPFI $9.71
- AMRN $18.01
- Resistance Level
- OPFI $10.45
- AMRN $20.43
- Average True Range (ATR)
- OPFI 0.49
- AMRN 0.97
- MACD
- OPFI -0.15
- AMRN 0.22
- Stochastic Oscillator
- OPFI 9.17
- AMRN 89.70
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.